NCT00574184 Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI) Status COMPLETED Phase N/A
NCT00573209 Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction Status UNKNOWN Phase PHASE1
NCT00569413 A Combined Psycho-pharmacological and Brain Imaging Study of Human Sexuality Status SUSPENDED Phase N/A
NCT00555087 Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate Status UNKNOWN Phase PHASE4
NCT00507286 Efficacy and Safety Study of Combined Oral and Injection Therapy for Erectile Dysfunction Status UNKNOWN Phase NA
NCT00492635 Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED Status COMPLETED Phase PHASE3
NCT00489606 Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530 Status COMPLETED Phase PHASE1
NCT00489450 Phase I Study to Investigate the Alcohol Interaction of SK3530 Status COMPLETED Phase PHASE1
NCT00470873 Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men Status COMPLETED Phase N/A
NCT00468650 A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction. Status COMPLETED Phase PHASE4
NCT00463957 The Pharmacological Basis for the Increase in Visual Time Constants Induced by Single Oral Doses of Sildenafil Status UNKNOWN Phase NA
NCT00443625 Phase 1 Study of SK3530 to Investigate of the Effect of Food Status COMPLETED Phase PHASE1
NCT00422578 Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction Status COMPLETED Phase PHASE4
NCT00421460 The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction Status COMPLETED Phase PHASE4
NCT00421083 Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury Status COMPLETED Phase PHASE3
NCT00415571 Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors Status COMPLETED Phase PHASE2
NCT00382135 A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg Status COMPLETED Phase PHASE4
NCT00381732 A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction Status COMPLETED Phase PHASE3